CA1116518A
(fr)
*
|
1977-09-30 |
1982-01-19 |
Guido Neri |
Methode pour purifier une suspension de liposomes
|
IT1111367B
(it)
*
|
1978-11-17 |
1986-01-13 |
Serono Ist Farm |
Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
|
DE2914788A1
(de)
*
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
|
DE2914789A1
(de)
*
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Injizierbare arzneimittel mit entzuendungshemmender wirkung
|
HU184141B
(en)
*
|
1979-12-27 |
1984-07-30 |
Human Oltoanyagtermelo |
Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
|
JPS56135416A
(en)
*
|
1980-03-27 |
1981-10-22 |
Mitsubishi Chem Ind Ltd |
Pharmaceutical preparation for skin
|
JPS56161317A
(en)
*
|
1980-05-15 |
1981-12-11 |
Green Cross Corp:The |
Pharmaceutical preparation of fatty corpuscle of steroid
|
EP0072936B1
(fr)
*
|
1981-08-12 |
1985-12-18 |
A. Nattermann & Cie. GmbH |
0-Alkyl-0-carbamoyl-glycéro-phosphocholines et procédé de leur préparation
|
EP0088046B1
(fr)
*
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipides en phase aqueuse
|
ZA831053B
(en)
*
|
1982-02-17 |
1985-03-27 |
Ciba Geigy Ag |
Lipids in aqueous phase
|
JPS58201712A
(ja)
*
|
1982-05-18 |
1983-11-24 |
Green Cross Corp:The |
脂肪乳剤
|
DE3228629A1
(de)
*
|
1982-07-31 |
1984-02-02 |
Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß |
Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
|
MX9203290A
(es)
*
|
1983-09-19 |
1992-08-01 |
Liposome Co Inc |
Suministro localizado usando conjugados de fibronectina.
|
SE8403905D0
(sv)
*
|
1984-07-30 |
1984-07-30 |
Draco Ab |
Liposomes and steroid esters
|
CA1260393A
(fr)
*
|
1984-10-16 |
1989-09-26 |
Lajos Tarcsay |
Liposomes de lipides synthetiques
|
US4921706A
(en)
*
|
1984-11-20 |
1990-05-01 |
Massachusetts Institute Of Technology |
Unilamellar lipid vesicles and method for their formation
|
US4983397A
(en)
*
|
1985-08-19 |
1991-01-08 |
Board Of Regents, University Of Texas System |
Pharmaceutical compositions consisting of acylated phospholipids
|
US5622713A
(en)
*
|
1985-09-17 |
1997-04-22 |
The Regents Of The University Of California |
Method of detoxifying animal suffering from overdose
|
IE58981B1
(en)
*
|
1985-10-15 |
1993-12-15 |
Vestar Inc |
Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
|
EP0244405B1
(fr)
*
|
1985-10-31 |
1991-10-23 |
Kv Pharmaceutical Company |
Systemes de liberation d'agents actifs dans le vagin
|
US5266329A
(en)
*
|
1985-10-31 |
1993-11-30 |
Kv Pharmaceutical Company |
Vaginal delivery system
|
DE3683606D1
(de)
*
|
1985-11-27 |
1992-03-05 |
Ethicon Inc |
Hemmung der postoperativen adhaesionsbildung durch topische verabreichung eines entzuendungshemmenden nichtsteroiden wirkstoffs.
|
IN166447B
(fr)
*
|
1985-11-27 |
1990-05-12 |
Ethicon Inc |
|
DE3542773A1
(de)
*
|
1985-12-04 |
1987-06-11 |
Roehm Pharma Gmbh |
Hautwirksame pharmaka mit liposomen als wirkstofftraeger
|
EP0234897A3
(fr)
*
|
1986-02-24 |
1987-11-19 |
Ethicon, Inc. |
Inhibition de la formation de l'adhérence post-chirurgicale par l'administration topique continue de glucocorticoides
|
US4808576A
(en)
*
|
1986-04-28 |
1989-02-28 |
Mobay Corporation |
Remote administration of hyaluronic acid to mammals
|
CA1257199A
(fr)
*
|
1986-05-20 |
1989-07-11 |
Paul Y. Wang |
Preparation contenant une substance macromoleculaire ayant des proprietes biologiques liberee pendant plusieurs mois in vivo
|
US6759057B1
(en)
|
1986-06-12 |
2004-07-06 |
The Liposome Company, Inc. |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
AU7543887A
(en)
*
|
1986-06-12 |
1988-01-11 |
Liposome Company, Inc., The |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
US4877619A
(en)
*
|
1986-08-25 |
1989-10-31 |
Vestar, Inc. |
Liposomal vesicles for intraperitoneal administration of therapeutic agents
|
US5202126A
(en)
*
|
1987-08-20 |
1993-04-13 |
Parfums Christian Dior |
Composition containing pregnenolone or a pregnenolone ester incorporated in liposomes, and a method for regenerating, or revitalizing the skin therewith
|
FR2619505B1
(fr)
*
|
1987-08-20 |
1990-08-31 |
Dior Christian Parfums |
Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
|
US5403592A
(en)
*
|
1987-08-25 |
1995-04-04 |
Macnaught Pty Limited |
Lubricant composition for rheumatism
|
US4950432A
(en)
*
|
1987-10-16 |
1990-08-21 |
Board Of Regents, The University Of Texas System |
Polyene microlide pre-liposomal powders
|
US4946683A
(en)
*
|
1987-11-18 |
1990-08-07 |
Vestar, Inc. |
Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
|
US4915951A
(en)
*
|
1987-12-03 |
1990-04-10 |
California Institute Of Technology |
Cryoprotective reagent
|
GB2217596A
(en)
*
|
1988-04-26 |
1989-11-01 |
American Cyanamid Co |
Anti-arthritic liposome composition
|
ATE145337T1
(de)
*
|
1988-05-02 |
1996-12-15 |
Phanos Tech Inc |
Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
|
FR2637182B1
(fr)
*
|
1988-10-03 |
1992-11-06 |
Lvmh Rech |
Compositions a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un ecdysteroide, de preference l'ecdysterone, ou l'un de ses derives; et compositions cosmetiques, pharmaceutiques, notamment dermatologiques, de sericulture ou phytosanitaires l'incorporant
|
US5015483A
(en)
*
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
US5139803A
(en)
*
|
1989-02-09 |
1992-08-18 |
Nabisco, Inc. |
Method and liposome composition for the stabilization of oxidizable substances
|
US5356633A
(en)
*
|
1989-10-20 |
1994-10-18 |
Liposome Technology, Inc. |
Method of treatment of inflamed tissues
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US6088613A
(en)
*
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US20020150539A1
(en)
*
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
DE4108902A1
(de)
*
|
1990-08-06 |
1992-02-13 |
Nattermann A & Cie |
Wasserhaltiges liposomensystem
|
EP0560900B1
(fr)
*
|
1990-12-03 |
1995-02-08 |
Vestar, Inc. |
Prevention d'adherences synoviales
|
GB9106686D0
(en)
*
|
1991-03-28 |
1991-05-15 |
Hafslund Nycomed As |
Improvements in or relating to contrast agents
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
CA2124329C
(fr)
*
|
1991-11-27 |
2008-11-18 |
Gregory A. Kopia |
Composes, compositions et methodes de fixation de substances bio-actives aux membranes de surface de bio-particules
|
GB9200388D0
(en)
*
|
1992-01-09 |
1992-02-26 |
Nycomed As |
Improvements in or relating to contrast agents
|
ATE192327T1
(de)
*
|
1993-03-24 |
2000-05-15 |
Collaborative Lab Inc |
Kosmetisches verabreichungssystem für salizylsäure und verfahren zur herstellung desselben
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US20040208922A1
(en)
*
|
1995-06-07 |
2004-10-21 |
The Regents Of The University Of California |
Method for loading lipid like vesicles with drugs or other chemicals
|
US6521211B1
(en)
*
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
WO1997014407A1
(fr)
*
|
1995-10-17 |
1997-04-24 |
Research Triangle Pharmaceuticals |
Administration de medicaments insolubles
|
CA2252617A1
(fr)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Procedes d'apport de composes dans une cellule
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
DK1323434T3
(da)
*
|
1996-09-11 |
2007-11-12 |
Bristol Myers Squibb Medical I |
Fremgangsmåde til diagnostisk billeddannelse af nyreregioner under anvendelse af et kontrastmiddel og en vasodilator
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
US5827532A
(en)
*
|
1997-01-31 |
1998-10-27 |
The Reagents Of The University Of California |
Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
|
US6537246B1
(en)
*
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US20050019266A1
(en)
*
|
1997-05-06 |
2005-01-27 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
DE69908304T2
(de)
*
|
1998-02-11 |
2004-02-19 |
Rtp Pharma Corp. |
Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
EP1079808B1
(fr)
|
1998-05-29 |
2004-02-11 |
Skyepharma Canada Inc. |
Compositions de microparticules a protection thermique et procede de sterilisation a la vapeur apres conditionnement
|
DK1105096T3
(da)
|
1998-08-19 |
2004-03-08 |
Skyepharma Canada Inc |
Injicerbare vandige propofoldispersioner
|
US7939105B2
(en)
|
1998-11-20 |
2011-05-10 |
Jagotec Ag |
Process for preparing a rapidly dispersing solid drug dosage form
|
US6667299B1
(en)
*
|
2000-03-16 |
2003-12-23 |
Hollis-Eden Pharmaceuticals, Inc. |
Pharmaceutical compositions and treatment methods
|
EP1214059B1
(fr)
*
|
1999-09-21 |
2005-05-25 |
Skyepharma Canada Inc. |
Compositions particulaires, a surface modifiee, de substances biologiquement actives
|
DK1955700T3
(da)
|
1999-09-30 |
2011-05-23 |
Harbor Biosciences Inc |
Terapeutisk behandling af androgenreceptor-betingede lidelser
|
US6710038B1
(en)
|
1999-12-14 |
2004-03-23 |
Kibun Food Chemifa Co., Ltd. |
Emulsification method using propylene glycol hyaluronate
|
CA2407027C
(fr)
|
2000-04-20 |
2011-02-15 |
Rtp Pharma Inc. |
Procede ameliore destine aux particules de medicament insolubles dans l'eau
|
CU23175A1
(es)
*
|
2000-07-17 |
2006-09-22 |
Ct De Investigacion Y Desarrol |
Formulacion liposomica de propionato de clobetasol
|
JP4969761B2
(ja)
|
2000-08-31 |
2012-07-04 |
オバン・エナジー・リミテッド |
所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
|
AU2001255515A1
(en)
*
|
2000-09-20 |
2002-04-02 |
Skyepharma Canada Inc. |
Stabilised fibrate microparticles
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
NZ527408A
(en)
*
|
2001-02-22 |
2005-04-29 |
Skyepharma Canada Inc |
Hydroxymethylglutarylcoenzyme A (HMG CoA) reductase inhibitor (or a statin) and a fibrate in a single effective oral dosage form to treat dyslipidaemia and dyslipoproteinaemia
|
CA2439687A1
(fr)
|
2001-03-01 |
2002-09-12 |
Hollis-Eden Pharmaceuticals, Inc. |
Traitement de deficiences affectant les globules sanguins
|
FR2827765B1
(fr)
*
|
2001-07-27 |
2003-09-19 |
Oreal |
Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea
|
WO2003090681A2
(fr)
*
|
2002-04-24 |
2003-11-06 |
Research Development Foundation |
Effets synergetiques des inhibiteurs du facteur nf-kb de transcription nucleaire et d'agents anti-cancereux
|
WO2004000229A2
(fr)
*
|
2002-06-24 |
2003-12-31 |
Research Development Foundation |
Traitement du myelome multiple humain par la curcumine
|
AU2003265576A1
(en)
*
|
2002-08-23 |
2004-03-11 |
The Mclean Hospital Corporation |
Corticosteroid conjugates and uses thereof
|
DE10255106A1
(de)
*
|
2002-11-24 |
2004-06-09 |
Novosom Ag |
Liposomale Glucocorticoide
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US7344716B2
(en)
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
US8273347B2
(en)
*
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
WO2005011633A1
(fr)
*
|
2003-08-01 |
2005-02-10 |
National Institute Of Advanced Industrial Science And Technology |
Remede contre les maladies inflammatoires ou produit pour les diagnostiquer, contenant des liposomes cibleurs
|
WO2005020958A2
(fr)
*
|
2003-08-26 |
2005-03-10 |
Research Development Foundation |
Administration par aerosol de curcumine
|
WO2006046934A2
(fr)
|
2003-08-26 |
2006-05-04 |
Research Development Foundation |
Inhibiteurs de l'osteoclastogenese et utilisations de ceux-ci
|
WO2005034915A2
(fr)
*
|
2003-10-03 |
2005-04-21 |
Alza Corporation |
Procede de criblage pour l'evaluation de l'interaction bicouche-medicament dans des compositions liposomiques
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
US20050255154A1
(en)
|
2004-05-11 |
2005-11-17 |
Lena Pereswetoff-Morath |
Method and composition for treating rhinitis
|
CA2582231A1
(fr)
|
2004-09-29 |
2006-10-19 |
Hollis-Eden Pharmaceuticals, Inc. |
Analogues de steroides et leurs utilisations
|
MX2007015577A
(es)
*
|
2005-06-09 |
2008-02-25 |
Biolipox Ab |
Metodo y composiciones para el tratamiento de trastornos inflamatorios.
|
WO2007026151A1
(fr)
*
|
2005-09-01 |
2007-03-08 |
Biolipox Ab |
Composition de liposome contenant un antihistaminique et un corticosteroide et son utilisation pour la fabrication d'un medicament pour traiter la rhinite et les troubles associes
|
CA2697160A1
(fr)
*
|
2007-08-21 |
2009-02-26 |
Harbor Biosciences, Inc. |
Compositions et formulations therapeutiques stabilisees
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
US20120028335A1
(en)
|
2010-07-28 |
2012-02-02 |
Life Technologies Corporation |
Anti-viral azide-containing compounds
|
US20130209550A1
(en)
|
2010-07-28 |
2013-08-15 |
Life Technologies Corporation |
Anti-Viral Azide Containing Compounds
|
CN108977412A
(zh)
|
2012-01-26 |
2018-12-11 |
生命科技公司 |
用于提高病毒感染性的方法
|
US20150125438A1
(en)
*
|
2012-07-20 |
2015-05-07 |
Sang Jae Kim |
Anti-Inflammatory Peptides and Composition Comprising the Same
|
AU2014235854B2
(en)
|
2013-03-21 |
2019-04-11 |
Eupraxia Pharmaceuticals USA LLC |
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
|
ES2672993T3
(es)
|
2015-10-27 |
2018-06-19 |
Eupraxia Pharmaceuticals Inc. |
Formulaciones de liberación sostenida de anestésicos locales
|
CN105732756B
(zh)
*
|
2016-01-29 |
2017-11-03 |
首都师范大学 |
一种脂溶性地塞米松衍生物的纯化方法
|
US10836788B2
(en)
|
2019-02-05 |
2020-11-17 |
SD Chem, Inc. |
Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
|